Literature DB >> 6868215

Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine.

P C Hallson, G A Rose, S Sulaiman.   

Abstract

Crystal formation in whole urine was studied by the technique of rapid evaporation to 1,250 mosmol/l with and without raising citrate concentration by 40-50%. The added citrate reduced calcium oxalate crystal formation at pH 5.3 by about 25% and reduced calcium phosphate crystal formation at pH 6.8 by some 42%. These results support the view that citrate is important in maintaining calcium in solution in whole urine, and that raising the urinary citrate could be effective treatment for calcium oxalate/phosphate urolithiasis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6868215     DOI: 10.1159/000280885

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  18 in total

1.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

Review 2.  Recent advances in the identification and management of inherited hyperoxalurias.

Authors:  David J Sas; Peter C Harris; Dawn S Milliner
Journal:  Urolithiasis       Date:  2018-12-10       Impact factor: 3.436

Review 3.  Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Authors:  R L Ryall
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Stone symptoms and urinary deposits.

Authors:  Y M Fazil Marickar; Abiya Salim; Adarsh Vijay
Journal:  Urol Res       Date:  2009-11-04

5.  Metabolic disorders in patients with calcium urolithiasis.

Authors:  M Butz
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

6.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.

Authors:  P O Schwille; U Herrmann; C Wolf; I Berger; R Meister
Journal:  Urol Res       Date:  1992

7.  Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats.

Authors:  Jun Mi; Jianmin Duan; Jun Zhang; Jianzhong Lu; Hanzhang Wang; Zhiping Wang
Journal:  Urol Res       Date:  2011-08-06

8.  A method for studying inhibitory activity in whole urine.

Authors:  R L Ryall; C M Hibberd; V R Marshall
Journal:  Urol Res       Date:  1985

Review 9.  Urine citrate and renal stone disease.

Authors:  H Goldberg; L Grass; R Vogl; A Rapoport; D G Oreopoulos
Journal:  CMAJ       Date:  1989-08-01       Impact factor: 8.262

10.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium sodium citrate administered as short-, medium- and long-term to male stone patients.

Authors:  U Herrmann; P O Schwille; H Schwarzlaender; I Berger; G Hoffmann
Journal:  Urol Res       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.